Incorporation of immunotherapy into the treatment of metastatic neuroendocrine carcinoma of the cervix: A case report

• Ideal treatment for advanced neuroendocrine carcinoma of the cervix (NECC) remains unclear. • A patient with metastatic NECC experienced a durable complete response to multi-modal therapy that included atezolizumab. • Atezolizumab may improve response rates and overall survival when incorporated i...

Descripción completa

Detalles Bibliográficos
Autores principales: Suresh, Akanksha, Ferriss, James Stuart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474144/
https://www.ncbi.nlm.nih.gov/pubmed/37663173
http://dx.doi.org/10.1016/j.gore.2023.101263
Descripción
Sumario:• Ideal treatment for advanced neuroendocrine carcinoma of the cervix (NECC) remains unclear. • A patient with metastatic NECC experienced a durable complete response to multi-modal therapy that included atezolizumab. • Atezolizumab may improve response rates and overall survival when incorporated into therapy for NECC.

Ejemplares similares